JPY1,719.00
0.70% today
Tokyo, Sep 03, 08:16 am CET
ISIN
JP3197600004
Symbol
4528

Ono Pharmaceutical Stock price

JPY1,725.50
+73.00 4.42% 1M
+101.00 6.22% 6M
+91.00 5.57% YTD
-368.50 17.60% 1Y
-1,617.50 48.38% 3Y
-1,567.50 47.60% 5Y
-1,342.50 43.76% 10Y
+604.01 53.86% 20Y
Tokyo, Closing price Wed, Sep 03 2025
+18.50 1.08%
ISIN
JP3197600004
Symbol
4528
Industry

Key metrics

Basic
Market capitalization
JPY799.8b
Enterprise Value
JPY797.9b
Net debt
positive
Cash
JPY140.0b
Shares outstanding
469.8m
Valuation (TTM | estimate)
P/E
18.7 | 11.4
P/S
1.6 | 1.6
EV/Sales
1.6 | 1.6
EV/FCF
25.1
P/B
1.0
Dividends
DPS
JPY80.00
Yield 1Y | 5Y
4.7% | 2.9%
Growth 1Y | 5Y
0.0% | 9.9%
Payout 1Y | 3Y
75.1% | 38.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
JPY496.7b | JPY504.0b
EBITDA
JPY82.8b | JPY114.9b
EBIT
JPY51.1b | JPY111.1b
Net Income
JPY42.9b | JPY70.3b
Free Cash Flow
JPY31.8b
Growth (TTM | estimate)
Revenue
-0.7% | 3.5%
EBITDA
-50.5% | 77.0%
EBIT
-65.8% | 80.8%
Net Income
-64.5% | 40.5%
Free Cash Flow
-69.8%
Margin (TTM | estimate)
Gross
68.7%
EBITDA
16.7% | 22.8%
EBIT
10.3%
Net
8.6% | 14.0%
Free Cash Flow
6.4%
Financial Health
Equity Ratio
73.5%
Return on Equity
6.4%
ROCE
5.7%
ROIC
5.7%
Debt/Equity
0.2
More
EPS
JPY91.4
FCF per Share
JPY67.6
Short interest
-
Employees
4k
Rev per Employee
JPY126.4m
Show more

Is Ono Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Ono Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Ono Pharmaceutical forecast:

1x Buy
5%
9x Hold
47%
9x Sell
47%

Analyst Opinions

19 Analysts have issued a Ono Pharmaceutical forecast:

Buy
5%
Hold
47%
Sell
47%

Financial data from Ono Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
496,732 496,732
1% 1%
100%
- Direct Costs 155,292 155,292
23% 23%
31%
341,440 341,440
9% 9%
69%
- Selling and Administrative Expenses 128,871 128,871
23% 23%
26%
- Research and Development Expense 157,261 157,261
35% 35%
32%
82,805 82,805
50% 50%
17%
- Depreciation and Amortization 31,753 31,753
77% 77%
6%
EBIT (Operating Income) EBIT 51,052 51,052
66% 66%
10%
Net Profit 42,926 42,926
65% 65%
9%

In millions JPY.

Don't miss a Thing! We will send you all news about Ono Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Head office Japan
CEO Gyo Sagara
Employees 3,853
Founded 1947
Website www.ono-pharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today